- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Patent holdings for IPC class A61K 47/68
Total number of patents in this class: 11793
10-year publication summary
378
|
567
|
989
|
1225
|
1204
|
1426
|
1485
|
1566
|
1553
|
781
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
SeaGen Inc | 580 |
250 |
Regeneron Pharmaceuticals, Inc. | 4223 |
200 |
Daiichi Sankyo Company, Limited | 1852 |
198 |
Genentech, Inc. | 3961 |
194 |
MedImmune Limited | 611 |
149 |
Hanmi Pharm. Co., Ltd. | 569 |
148 |
ImmunoGen, Inc. | 399 |
130 |
Dyne Therapeutics, Inc. | 238 |
127 |
The Regents of the University of California | 19812 |
115 |
Novartis AG | 10904 |
91 |
Bristol-myers Squibb Company | 4892 |
90 |
Bolt Biotherapeutics, Inc. | 119 |
90 |
Pfizer Inc. | 3367 |
76 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 279 |
66 |
ADC Therapeutics SA | 126 |
65 |
Hoffmann-La Roche Inc. | 3379 |
60 |
Memorial Sloan-Kettering Cancer Center | 1910 |
59 |
Abbvie Inc. | 1802 |
58 |
CytomX Therapeutics, Inc. | 216 |
58 |
Hangzhou DAC Biotech Co., Ltd | 102 |
58 |
Other owners | 9511 |